Arkolith/Insider Trading/KNSA/Form 4

Paolini John F.

CHIEF MEDICAL OFFICERKiniksa Pharmaceuticals International, plc (KNSA) · full profile →Form 4 · filed Nov 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.1M
Net Open-Market Flow
-$3.1M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 31, 2025Option exercise(M)37K$3.80$139K98K
Oct 31, 2025Option exercise(M)46K$8.83$406K144K
Oct 31, 2025Sell(S)83K$37.14$3.1M61K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 31, 2025Option exercise(M)37K—$00
Oct 31, 2025Option exercise(M)46K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001741533-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML